Others would be able to answer better than myself - however my understanding is that there still can be some due dilligence involved. That being said - revenue is pretty much guranteed with this stock, so its not like we are dependant on FDA approval in the first indication. If we were - i'd say there is a reason to hold off.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $151.6M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 24.0¢ | 23.3¢ | $167.9K | 709.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 386232 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 301609 | 5 |
View Market Depth
| Last trade - 16.10pm 28/07/2025 (20 minute delay) ? |
| EIQ (ASX) Chart |